Jian Jin, PhD, an associate professor and director of medicinal chemistry in the Center for Integrative Chemical Biology and Drug Discovery at UNC-Chapel Hill, is featured in endeavors magazine.
CHAPEL HILL, N.C. - Patients who have high-risk non-melanoma skin carcinomas of the head and neck may benefit from concomitant radiotherapy and chemotherapy, according to a UNC-led study. Their study is the first to report on multiple patients with these skin carcinomas treated simultaneously with radio-and chemotherapy.
Noel Brewer, a professor of public health at UNC who has also studied HPV vaccine use, said the public controversy has been less harmful than the fact that many doctors simply don’t know or choose not to recommend it, or that many parents have insurance plans that don’t cover the vaccine or charge large co-pays for it.
Keith Amos, MD, quoted in The Huffington Post
Chapel Hill, NC – G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Channing Der and his wife, Kathy, had already planned a 30th wedding anniversary trip to Kenya. After hearing Carolina alumnus and author Rye Barcott talk about his book, It Happened on the Way to War: A Marine’s Path to Peace, and describe the Carolina for Kibera program in Nairobi, Kenya, they knew they had to see the program in action.
Toolkit moves best practices to the community
Chapel Hill - A team of UNC scientists report that in laboratory studies, overexpression of a specific protein could be used as a prognostic marker and as a guide for therapeutic choices for patients with head and neck cancer. Their findings appear in the September 9, 2011 online issue of the journal Clinical Cancer Research.
CHAPEL HILL – When sperm meets egg, the chemical instructions that tag sperm cells must be erased so that human life can start anew. One way these instructions are erased is through demethylation, the removal of specific chemical tags or methyl groups that dot the underlying DNA of cells. Though scientists have known about this phenomenon for a decade, exactly how such “reprogramming” occurs has proved elusive.
CHAPEL HILL, N.C. – Weili Lin, PhD, professor of radiology, neurology and biomedical engineering and director of the UNC Biomedical Research Imaging Center, has been appointed The Dixie Lee Boney Soo Distinguished Professor in Neurological Medicine.
Chapel Hill - A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor of Chemistry and Pharmacy, and colleagues report their finding online in advance of print on September 14, 2011 in Angewandte Chemie, the German-based flagship chemistry journal.
CHAPEL HILL – Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body’s own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.
CHAPEL HILL – A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person’s risk of schizophrenia and bipolar disorder.
Seventh annual event benefits cancer research and treatment in our community
Two recent grants from the National Science Foundation will support soft matter research at the University of North Carolina at Chapel Hill.
Kevin Weeks, a chemist at the University of North Carolina at Chapel Hill, has received an award from the National Institutes of Health to support innovative research on creating new drugs that work by binding to RNA.
UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.
Two UNC Lineberger faculty, Noel Brewer, PhD, associate professor of health behavior and health education in the UNC Gillings School of Global Public Health, and Karen Mohlke, PhD, associate professor of genetics in the UNC School of Medicine, have received the 2011 Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty at UNC-Chapel Hill.
Chapel Hill - Deciding whether or not to have breast reconstruction after mastectomy is highly challenging for many patients. Clara Lee, MD, MPP, a UNC School of Medicine physician/scientist, has received a five-year grant award to examine patients’ decision-making process about reconstruction and the effects of reconstruction on quality of life and body image. The $862,700.00 career development award to the plastic and reconstructive surgeon is from the National Institutes of Health.
Peer Connect provides training for cancer survivors who wish to "give back" by talking with or being a buddy to another patient or survivor. Peer Connect meets a need for more formalized training for the "guides" or peer counselors by teaching effective communication skills and strategies based on Motivational Interviewing (MI), which focuses on listening and meeting the needs of the recipient rather than giving advice or telling people what to do.